Charles River Laboratories

Charles River Laboratories is a global contract research organization (CRO) that provides a wide range of preclinical and clinical research services to support the development of pharmaceutical, biotechnology, and medical device products. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts, United States.

Charles River Laboratories offers a comprehensive suite of research and development services, including laboratory animal models, preclinical safety assessment, discovery and safety pharmacology, clinical support services, and manufacturing and testing of biologics and vaccines. They work with clients throughout the drug development process, from early-stage research to regulatory approval and post-market support.

For more than 75 years, Charles River has provided the people and patients who need them with solutions to quicken the development of medications, chemicals, and medical devices. From fundamental research, discovery, and safety evaluation to production and commercialization, their goods and services help clients. The comprehensive approach allows maximum speed and confidence on the drive to market thanks to this broad end-to-end portfolio, worldwide capacity, and proven scientific and regulatory consultants.

Founded: 1947

Headquarters: USA

Website: https://www.criver.com/